Published in Br J Pharmacol on March 01, 2000
Potent anti-inflammatory and antinociceptive activity of the endothelin receptor antagonist bosentan in monoarthritic mice. Arthritis Res Ther (2011) 1.42
Endothelin receptors and pain. J Pain (2009) 1.27
Mechanism of cancer pain. Mol Interv (2010) 1.00
Endothelins contribute towards nociception induced by antigen in ovalbumin-sensitised mice. Br J Pharmacol (2004) 0.97
Endothelin potentiates TRPV1 via ETA receptor-mediated activation of protein kinase C. Mol Pain (2007) 0.97
Involvement of endogenous endothelins in thermal and mechanical inflammatory hyperalgesia in mice. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.95
Endothelin. Pharmacol Rev (2016) 0.95
Re-expression of the methylated EDNRB gene in oral squamous cell carcinoma attenuates cancer-induced pain. Pain (2011) 0.92
Role of peripheral endothelin receptors in an animal model of complex regional pain syndrome type 1 (CRPS-I). Pain (2010) 0.90
Tumor-evoked sensitization of C nociceptors: a role for endothelin. J Neurophysiol (2008) 0.90
Endothelin receptor antagonists. World J Urol (2005) 0.89
Targeting endothelin ETA and ETB receptors inhibits antigen-induced neutrophil migration and mechanical hypernociception in mice. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.89
Endothelin-1 as a target for therapeutic intervention in prostate cancer. Invest New Drugs (2002) 0.86
Molecular and cellular mechanisms that initiate pain and itch. Cell Mol Life Sci (2015) 0.84
Endogenous endothelin stimulates cardiac sympathetic afferents during ischaemia. J Physiol (2010) 0.84
Dual Roles for Endothelin-B Receptors in Modulating Adjuvant-Induced Inflammatory Hyperalgesia in Rats. Open Pain J (2009) 0.83
Epigenetic regulation of persistent pain. Transl Res (2014) 0.80
Evidence for the endothelin system as an emerging therapeutic target for the treatment of chronic pain. J Pain Res (2014) 0.77
Effect of short-term hyperinsulinemia on the localization and expression of endothelin receptors A and B in lamellar tissue of the forelimbs of horses. Am J Vet Res (2014) 0.75
Cerebral activation during von Frey filament stimulation in subjects with endothelin-1-induced mechanical hyperalgesia: a functional MRI study. Biomed Res Int (2013) 0.75
Effects of repeated central administration of endothelin type A receptor antagonist on the development of neuropathic pain in rats. Biomed Res Int (2013) 0.75
Endothelin-1 (ET-1) and its receptors on haemorrhoidal tissue: a potential site for therapeutic intervention. Br J Pharmacol (2017) 0.75
Endothelin B receptors exert antipruritic effects via peripheral κ-opioid receptors. Exp Ther Med (2012) 0.75
Endothelin-3 at low concentrations attenuates inflammatory responses via the endothelin B2 receptor. Inflamm Res (2013) 0.75
Ethical guidelines for investigations of experimental pain in conscious animals. Pain (1983) 17.70
Cloning and expression of a cDNA encoding an endothelin receptor. Nature (1991) 7.26
Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature (1991) 7.11
The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain (1987) 6.37
Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci (1992) 4.39
The induction of pain: an integrative review. Prog Neurobiol (1999) 3.70
Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun (1989) 1.61
Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist. J Pharmacol Exp Ther (1996) 1.38
Behavioral signs of acute pain produced by application of endothelin-1 to rat sciatic nerve. Neuroreport (1998) 1.32
Endothelin-1 participation in overt and inflammatory pain. J Cardiovasc Pharmacol (1989) 1.31
International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol Rev (1994) 1.19
Endothelin-1 is induced by cytokines in human vascular smooth muscle cells: evidence for intracellular endothelin-converting enzyme. Mol Pharmacol (1999) 1.17
Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reaction. J Hypertens (1990) 1.13
Endothelin localizes in the dorsal horn and acts on the spinal neurones: possible involvement of dihydropyridine-sensitive calcium channels and substance P release. Neurosci Lett (1989) 1.07
Endothelin 1 mediates ex vivo coronary vasoconstriction caused by exogenous and endogenous cytokines. Proc Natl Acad Sci U S A (1995) 1.05
Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor. Br J Pharmacol (1999) 1.05
The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord. Neuropharmacology (1992) 1.04
Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci Lett (1993) 0.97
Endothelin-1 enhances vascular permeability in the rat heart through the ETA receptor. Eur J Pharmacol (1992) 0.97
Acute pro-inflammatory actions of endothelin-1 in the guinea-pig lung: involvement of ETA and ETB receptors. Br J Pharmacol (1995) 0.96
Endothelin-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine. Biochem Biophys Res Commun (1990) 0.94
Phosphoramidon does not inhibit endogenous endothelin-1 release stimulated by hemorrhage, cytokines and hypoxia in rats. Eur J Pharmacol (1994) 0.93
Endothelin B receptor modulates inflammatory pain and cutaneous inflammation. Mol Pharmacol (1999) 0.93
Endothelin-induced nociception in mice: mediation by ETA and ETB receptors. J Pharmacol Exp Ther (1996) 0.92
Effects of endothelin-1 on capsaicin-induced nociception in mice. Eur J Pharmacol (1998) 0.91
Enhancement by endothelin-1 of microvascular permeability via the activation of ETA receptors. Br J Pharmacol (1993) 0.91
Endothelin-1 induces a histamine-dependent flare in vivo, but does not activate human skin mast cells in vitro. Br J Clin Pharmacol (1992) 0.88
ETA receptor antagonists inhibit allergic inflammation in the mouse. J Cardiovasc Pharmacol (1995) 0.86
Endothelin-1, one of the most potent histamine releasers in mouse peritoneal mast cells. Eur J Pharmacol (1994) 0.85
Endothelins potentiate formalin-induced nociception and paw edema in mice. Can J Physiol Pharmacol (1997) 0.85
Endothelin-1 enhances capsaicin-induced peptide release and cGMP accumulation in cultures of rat sensory neurons. Neurosci Lett (1994) 0.85
Endothelin-1 induces vasodilation in human skin by nociceptor fibres and release of nitric oxide. Br J Clin Pharmacol (1998) 0.85
Role of endothelin in mediating neurogenic plasma extravasation in rat dura mater. Pain (1996) 0.84
Essential role for endothelin ET(B) receptors in fever induced by LPS (E. coli) in rats. Br J Pharmacol (1998) 0.83
Endothelin-1 stimulates human monocytes in vitro to release TNF-alpha , IL-1beta and IL-6. Mediators Inflamm (1993) 0.82
Endothelin-1, -2 and -3 directly and big-endothelin-1 indirectly elicit an abdominal constriction response in mice. Life Sci (1991) 0.81
Role of endothelin-1 in carrageenin-induced inflammation. Int J Tissue React (1992) 0.81
Endothelin-1 enhances vascular cell adhesion molecule-1 expression in tumor necrosis factor alpha-stimulated vascular endothelial cells. Eur J Pharmacol (1999) 0.81
Quantitative autoradiographic localisation of [125I]endothelin-1 binding sites in spinal cord and dorsal root ganglia of the rat. Neurosci Lett (1991) 0.81
Inhibitors of endothelin. Med Res Rev (1997) 0.80
Endothelin: from molecule to man. Br J Clin Pharmacol (1997) 0.80
Mechanisms of endothelin-induced macromolecular leakage in microvascular beds of rat mesentery. Eur J Pharmacol (1993) 0.80
Endothelin receptor agonists and antagonists exhibit different dissociation characteristics. Biochim Biophys Acta (1994) 0.80
Effects of BQ-123, an ETA recepter-selective antagonist, on changes of intraocular pressure, blood-aqueous barrier and aqueous prostaglandin concentrations caused by endothelin-1 in rabbit. Jpn J Ophthalmol (1996) 0.79
ET-1 induces IL-6 gene expression in human umbilical vein endothelial cells: synergistic effect of IL-1. Am J Physiol (1996) 0.77
Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration "in vivo" by indirect mechanisms. Agents Actions (1990) 1.71
Effects of peptides and non-peptides on isolated arterial smooth muscles: role of endothelium. Eur J Pharmacol (1985) 1.64
Selective agonists for substance P and neurokinin receptors. Neuropeptides (1987) 1.51
Pharmacological receptors for substance P and neurokinins. Life Sci (1987) 1.50
Growth regulatory properties of endothelins. Peptides (1993) 1.35
The actions of kinin antagonists on B1 and B2 receptor systems. Eur J Pharmacol (1986) 1.31
Endothelins: circulating plasma levels and presence in other biologic fluids. Lab Invest (1993) 1.25
Receptors for substance P. I. The pharmacological preparations. Eur J Pharmacol (1984) 1.24
Different receptors are involved in the endothelium-mediated relaxation and the smooth muscle contraction of the rabbit pulmonary artery in response to substance P and related neurokinins. Eur J Pharmacol (1986) 1.24
Characterization of neurokinin receptors in various isolated organs by the use of selective agonists. Life Sci (1987) 1.14
Receptors for substance P and related neurokinins. Pharmacology (1989) 1.11
The rat isolated portal vein: a preparation sensitive to neurokinins, particularly neurokinin B. Eur J Pharmacol (1987) 1.08
The modulatory role played by TNF-alpha and IL-1 beta in the inflammatory responses induced by carrageenan in the mouse model of pleurisy. Cytokine (2001) 1.07
Processing of proendothelin-1 by human furin convertase. FEBS Lett (1995) 1.07
In vivo B1 kinin-receptor upregulation. Evidence for involvement of protein kinases and nuclear factor kappaB pathways. Br J Pharmacol (1999) 1.03
Nonadrenergic and noncholinergic arterial dilatation and venoconstriction are mediated by calcitonin gene-related peptide1 and neurokinin-1 receptors, respectively, in the mesenteric vasculature of the rat after perivascular nerve stimulation. J Pharmacol Exp Ther (1992) 1.01
Upregulation of B1 receptor mediating des-Arg9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin. Br J Pharmacol (1996) 0.98
Presence of a phosphoramidon-sensitive endothelin-converting enzyme which converts big-endothelin-1, but not big-endothelin-3, in the rat vas deferens. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.96
Conversion of kinins and their antagonists into B1 receptor activators and blockers in isolated vessels. Eur J Pharmacol (1986) 0.94
Pharmacology of kinins in the arterial and venous mesenteric bed of normal and B2 knockout transgenic mice. Eur J Pharmacol (1997) 0.94
Endothelin-1 inhibits PAF-induced paw oedema and pleurisy in the mouse. Br J Pharmacol (1992) 0.93
Analgesic activity of the lignans from Lychnophora ericoides. Phytochemistry (2000) 0.93
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test. Eur J Neurosci (2003) 0.92
Noradrenaline supersensitivity of the mouse vas deferns after long-term treatment with morphine. J Pharm Pharmacol (1977) 0.92
Hydrolysis of P2-purinoceptor agonists by a purified ectonucleotidase from the bovine aorta, the ATP-diphosphohydrolase. Biochem Pharmacol (1996) 0.92
DuP 753 is a specific antagonist for the angiotensin receptor. Hypertension (1991) 0.92
Effects of endothelin-1 on capsaicin-induced nociception in mice. Eur J Pharmacol (1998) 0.91
Is methylnalorphinium the prototype of an ideal peripheral analgesic? Eur J Pharmacol (1984) 0.90
Modulation of kinin B1 but not B2 receptors-mediated rat paw edema by IL-1beta and TNFalpha. Peptides (1998) 0.90
Endothelin-1 induces vasoconstriction and prostacyclin release via the activation of endothelin ETA receptors in the perfused rabbit kidney. Eur J Pharmacol (1993) 0.89
Heterozygous knock-Out of ET(B) receptors induces BQ-123-sensitive hypertension in the mouse. Hypertension (2000) 0.89
Undeca- and octa-peptide antagonists for substance P, a study on the guinea pig trachea. Eur J Pharmacol (1984) 0.88
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.88
In-vivo blockage of neutrophil migration by LPS is mimicked by a factor released from LPS-stimulated macrophages. Br J Exp Pathol (1989) 0.88
Interleukin-8 induces fever by a prostaglandin-independent mechanism. Am J Physiol (1994) 0.88
Effect of crude extracts from Leonotis nepetaefolia (Labiatae) on rat and guinea-pig smooth muscle and rat cardiac muscle. J Pharm Pharmacol (1991) 0.88
The use of confocal microscopy in the investigation of cell structure and function in the heart, vascular endothelium and smooth muscle cells. Mol Cell Biochem (1997) 0.88
Activities and antagonism of bombesin on urinary smooth muscles. Eur J Pharmacol (1985) 0.87
Endotoxin-induced fever is modulated by endogenous glucocorticoids in rats. Am J Physiol (1992) 0.87
Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice. Eur J Pharmacol (1996) 0.87
ET(B) receptor and nitric oxide synthase blockade induce BQ-123-sensitive pressor effects in the rabbit. Hypertension (1997) 0.87
Antispasmodic effects of an alkaloid extracted from Phyllanthus sellowianus: a comparative study with papaverine. Braz J Med Biol Res (1984) 0.87
Pharmacology of endothelins: vascular preparations for studying ETA and ETB receptors. Mol Cell Biochem (1996) 0.87
Dual effects of endothelins -1, -2 and -3 on guinea pig field-stimulated ileum: possible mediation by two receptors coupled to pertussis toxin-insensitive mechanisms. J Pharmacol Exp Ther (1992) 0.86
ETA receptor antagonists inhibit allergic inflammation in the mouse. J Cardiovasc Pharmacol (1995) 0.86
Novel inhibitors of nucleoside triphosphate diphosphohydrolases: chemical synthesis and biochemical and pharmacological characterizations. J Med Chem (2000) 0.86
A comparative study of the antipyretic effects of indomethacin and dipyrone in rats. Inflamm Res (2002) 0.86
Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists. Eur J Pharmacol (1985) 0.85
Endothelins potentiate formalin-induced nociception and paw edema in mice. Can J Physiol Pharmacol (1997) 0.85
Supersensitivity to noradrenaline in vas deferens from morphine-dependent mice is confirmed. Eur J Pharmacol (1983) 0.85
Effects of endothelin-1 on inflammatory incapacitation of the rat knee joint. J Cardiovasc Pharmacol (1998) 0.85
Different pressor and bronchoconstrictor properties of human big-endothelin-1, 2 (1-38) and 3 in ketamine/xylazine-anaesthetized guinea-pigs. Br J Pharmacol (1995) 0.85
Endothelin-1 (1-31): from chymase-dependent synthesis to cardiovascular pathologies. Vascul Pharmacol (2008) 0.85
Macrophages stimulated with lipopolysaccharide release a selective neutrophil chemotactic factor: an in vivo demonstration. Braz J Med Biol Res (1986) 0.85
Role of endothelins on lymphocyte accumulation in allergic pleurisy. J Leukoc Biol (2000) 0.84
Angiotensin II AT1 receptor internalization, translocation and de novo synthesis modulate cytosolic and nuclear calcium in human vascular smooth muscle cells. Can J Physiol Pharmacol (2003) 0.84
Bradykinin antagonism: differentiation between peptide antagonists and antiinflammatory agents. Eur J Pharmacol (1988) 0.84
Peripheral kinin B(1) and B(2) receptor-operated mechanisms are implicated in neuropathic nociception induced by spinal nerve ligation in rats. Neuropharmacology (2007) 0.84
Vasoactive peptides and their receptors. Blood Vessels (1990) 0.84
ET(B) receptor blockade potentiates the pressor response to big endothelin-1 but not big endothelin-2 in the anesthetized rabbit. Hypertension (2000) 0.84
Changes in paw oedema triggered via bradykinin B(1) and B(2) receptors in streptozotocin-diabetic rats. Eur J Pharmacol (2001) 0.83
Antagonists of substance P. Eur J Pharmacol (1982) 0.83
Pharmacological properties of endothelins and big endothelins in ketamine/xylazine or urethane anesthetized rats. Am J Hypertens (1995) 0.83
Essential role for endothelin ET(B) receptors in fever induced by LPS (E. coli) in rats. Br J Pharmacol (1998) 0.83
Molecular and pharmacological evidence for modulation of kinin B(1) receptor expression by endogenous glucocorticoids hormones in rats. Br J Pharmacol (2001) 0.83
Pharmacology of two novel mixed ETA/ETB receptor antagonists, BQ-928 and 238, in the carotid and pulmonary arteries and the perfused kidney of the rabbit. Br J Pharmacol (1997) 0.83
Effects of kinins on isolated blood vessels. Role of endothelium. Can J Physiol Pharmacol (1982) 0.83
Endogenous cannabinoids induce fever through the activation of CB1 receptors. Br J Pharmacol (2009) 0.83
Presence of functional endothelin-1 receptors in nuclear membranes of human aortic vascular smooth muscle cells. J Cardiovasc Pharmacol (2000) 0.82
Contribution of endogenous endothelin-1 and endothelin-A-receptors to the hypertensive state of endothelin-B heterozygous (+/-) knockout mice. J Cardiovasc Pharmacol (2000) 0.82
Role of R-type calcium channels in the response of the perfused arterial and venous mesenteric vasculature of the rat to platelet-activating factor. Br J Pharmacol (1994) 0.82
Inhibition of convertase-related processing of proendothelin-1. J Cardiovasc Pharmacol (1995) 0.82
Myrcene mimics the peripheral analgesic activity of lemongrass tea. J Ethnopharmacol (1991) 0.81
Potent constrictor actions of endothelin-1, endothelin-2, and endothelin-3 in rat isolated portal vein. Hypertension (1992) 0.81
A study of the trypanocidal and analgesic properties from Lychnophora granmongolense (Duarte) Semir & Leitão Filho. Phytother Res (2000) 0.81
Receptors for substance P. III. Classification by competitive antagonists. Eur J Pharmacol (1984) 0.81
Phosphoramidon-sensitive effects of big endothelins in the perfused rabbit kidney. Hypertension (1992) 0.81
Effects of cold-restraint and swim stress on convulsions induced by pentylenetetrazol and electroshock: influence of naloxone pretreatment. Pharmacol Biochem Behav (1991) 0.81
Chronic ethanol intake modulates vascular levels of endothelin-1 receptor and enhances the pressor response to endothelin-1 in anaesthetized rats. Br J Pharmacol (2008) 0.81
Characterization of kinin receptors modulating neurogenic contractions of the mouse isolated vas deferens. Br J Pharmacol (1995) 0.81
Effects of peptides and amines on isolated guinea pig tracheae as influenced by inhibitors of the metabolism of arachidonic acid. Pharmacology (1982) 0.81
Effects and mechanisms of action of endothelins on non-vascular smooth muscle of the respiratory, gastrointestinal and urogenital tracts. Regul Pept (1995) 0.81
Characterization of the endothelin-converting enzyme in guinea pig upper bronchus. J Cardiovasc Pharmacol (1995) 0.80
Endothelin 1 and thrombin synergistically stimulate IL-6 mRNA expression and protein production in human umbilical vein endothelial cells. J Cardiovasc Pharmacol (1995) 0.80
Receptors for neurokinins, tachykinins, and bombesin: a pharmacological study. Ann N Y Acad Sci (1988) 0.80
Receptors for substance P and neurokinins. Correlation between binding and biological activities. Eur J Pharmacol (1987) 0.80
Participation of endogenous endothelins in delayed eosinophil and neutrophil recruitment in mouse pleurisy. Inflamm Res (2000) 0.80
Substance P antagonists showing some selectivity for different receptor types. Eur J Pharmacol (1985) 0.80
Role of the neutral endopeptidase 24.11 in the conversion of big endothelins in guinea-pig lung parenchyma. Br J Pharmacol (1996) 0.80